168 related articles for article (PubMed ID: 38175345)
1. Estimating the Benefit of Preoperative Systemic Therapy to Reduce the Extent of Breast Cancer Surgery: Current Standard and Future Directions.
Montagna G
Cancer Treat Res; 2023; 188():149-174. PubMed ID: 38175345
[TBL] [Abstract][Full Text] [Related]
2. Regional Nodal Management After Preoperative Systemic Therapy.
Singer L; Weiss A; Bellon JR; King TA
Semin Radiat Oncol; 2022 Jul; 32(3):228-236. PubMed ID: 35688521
[TBL] [Abstract][Full Text] [Related]
3. Can axillary surgery be omitted in patients with breast pathologic complete response after neoadjuvant systemic therapy for breast cancer? A real-world retrospective study in China.
Chen R; Li S; Li Y; Zhu Q; Shi X; Xu L; Xu Y; Zhang W; Huang X; Wang J; Zha X
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3495-3501. PubMed ID: 34398298
[TBL] [Abstract][Full Text] [Related]
4. Primary systemic therapy of breast cancer.
Sachelarie I; Grossbard ML; Chadha M; Feldman S; Ghesani M; Blum RH
Oncologist; 2006 Jun; 11(6):574-89. PubMed ID: 16794237
[TBL] [Abstract][Full Text] [Related]
5. Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy.
Solá M; Margelí M; Castellá E; Cirauqui B; Mariscal A; Rull M; Julian JF; Luna M; Vallejo V; Fraile M
Breast; 2013 Oct; 22(5):908-13. PubMed ID: 23683695
[TBL] [Abstract][Full Text] [Related]
6. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
7. Axillary surgery in breast cancer: the beginning of the end.
Dumitru D; Khan A; Catanuto G; Rocco N; Nava MB; Benson JR
Minerva Chir; 2018 Jun; 73(3):314-321. PubMed ID: 29589679
[TBL] [Abstract][Full Text] [Related]
8. Real de-escalation or escalation in disguise?
Banys-Paluchowski M; Rubio IT; Ditsch N; Krug D; Gentilini OD; Kühn T
Breast; 2023 Jun; 69():249-257. PubMed ID: 36898258
[TBL] [Abstract][Full Text] [Related]
9. This house believes that: MARI/TAD is better than sentinel node biopsy after PST for cN+ patients.
van Hemert AKE; van Duijnhoven FH; Vrancken Peeters MTFD
Breast; 2023 Oct; 71():89-95. PubMed ID: 37562108
[TBL] [Abstract][Full Text] [Related]
10. Preoperative therapy: recent findings.
Kinoshita T
Breast Cancer; 2011 Apr; 18(2):80-4. PubMed ID: 21104352
[TBL] [Abstract][Full Text] [Related]
11. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
Franceschini G; Di Leone A; Natale M; Sanchez MA; Masett R
Ann Ital Chir; 2018; 89():290. PubMed ID: 30352955
[TBL] [Abstract][Full Text] [Related]
12. Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference.
Toi M; Benson JR; Winer EP; Forbes JF; von Minckwitz G; Golshan M; Robertson JF; Sasano H; Cole BF; Chow LW; Pegram MD; Han W; Huang CS; Ikeda T; Kanao S; Lee ES; Noguchi S; Ohno S; Partridge AH; Rouzier R; Tozaki M; Sugie T; Yamauchi A; Inamoto T
Breast Cancer Res Treat; 2012 Dec; 136(3):919-26. PubMed ID: 23143284
[TBL] [Abstract][Full Text] [Related]
13. Breast and axillary surgery after neoadjuvant systemic treatment - A review of clinical routine recommendations and the latest clinical research.
Pfob A; Heil J
Breast; 2022 Mar; 62 Suppl 1(Suppl 1):S7-S11. PubMed ID: 35135710
[TBL] [Abstract][Full Text] [Related]
14. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.
Kuerer HM; Sahin AA; Hunt KK; Newman LA; Breslin TM; Ames FC; Ross MI; Buzdar AU; Hortobagyi GN; Singletary SE
Ann Surg; 1999 Jul; 230(1):72-8. PubMed ID: 10400039
[TBL] [Abstract][Full Text] [Related]
15. Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype.
Di Micco R; Zuber V; Fiacco E; Carriero F; Gattuso MI; Nazzaro L; Panizza P; Gianolli L; Canevari C; Di Muzio N; Pasetti M; Sassi I; Zambetti M; Gentilini OD
Eur J Surg Oncol; 2019 Jun; 45(6):969-975. PubMed ID: 30744944
[TBL] [Abstract][Full Text] [Related]
16. Preoperative therapy in breast cancer: lessons from the treatment of locally advanced disease.
Wolff AC; Davidson NE
Oncologist; 2002; 7(3):239-45. PubMed ID: 12065797
[TBL] [Abstract][Full Text] [Related]
17. De-escalation of axillary irradiation for early breast cancer - Has the time come?
Senkus E; Cardoso MJ; Kaidar-Person O; Łacko A; Meattini I; Poortmans P
Cancer Treat Rev; 2021 Dec; 101():102297. PubMed ID: 34656018
[TBL] [Abstract][Full Text] [Related]
18. Contemporary management of the axilla in breast cancer.
Nurudeen S; Hunt KK
Clin Adv Hematol Oncol; 2018 Dec; 16(12):823-831. PubMed ID: 30843891
[TBL] [Abstract][Full Text] [Related]
19. Primary systemic therapy in operable breast cancer.
Wolff AC; Davidson NE
J Clin Oncol; 2000 Apr; 18(7):1558-69. PubMed ID: 10735905
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy.
Gianni L; Baselga J; Eiermann W; Guillem Porta V; Semiglazov V; Lluch A; Zambetti M; Sabadell D; Raab G; Llombart Cussac A; Bozhok A; Martinez-Agulló A; Greco M; Byakhov M; Lopez Lopez JJ; Mansutti M; Valagussa P; Bonadonna G;
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8715-21. PubMed ID: 16361558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
